Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study
Qiuhong Gong(Chinese Academy of Medical Sciences & Peking Union Medical College), Peter H. Bennett(National Institutes of Health), H. Li(China-Japan Friendship Hospital), Robert B. Gerzoff(Centers for Disease Control and Prevention), Shuai Yu(China-Japan Friendship Hospital), Yunfei An(Sichuan University), Edward W. Gregg(Imperial College London), Wenying Yang(China-Japan Friendship Hospital), John H. Zhang(Loma Linda University), Bo Zhang(China-Japan Friendship Hospital), Yuan Jiang, Yin Hu, J. Wang, G. Li(China-Japan Friendship Hospital), P. Zhang(Northwest A&F University), Gojka Roglić(Unknown)
Cited by 253
Related Papers
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
|The Lancet|2024|794
Rising rural body-mass index is the main driver of the global obesity epidemic in adults
|Nature|2019|743
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
|The Lancet Diabetes & Endocrinology|2016|728
Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002
|Annals of Internal Medicine|2006|575